DNAJA3 (Tid1) - DnaJ Heat Shock Protein Family Member A3
Introduction
Dnaja3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<table class="infobox infobox-protein"> [@zhang2019]
<tr> [@chen2010]
<th class="infobox-header" colspan="2">DNAJA3 (Tid1)</th> [@mccoy2021]
</tr> [@burbulla2022]
<tr> [@youle2012]
<td class="infobox-header" colspan="2">Mitochondrial Co-Chaperone</td> [@pickrell2015]
</tr> [@lin2006]
<tr>
<td class="label">Gene Symbol</td>
<td>DNAJA3</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>DnaJ Heat Shock Protein Family Member A3</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>Tid1, TID1, mitochondrial DnaJ protein</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[DNAJA3](/genes/dnaja3)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td><a href="https://www.uniprot.org/uniprot/Q96HS5" target="_blank">Q96HS5</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>48 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondria (inner membrane space and matrix)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Hsp40/DnaJ family (subfamily A)</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Ubiquitous; highest in heart, brain, skeletal muscle</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">19 edges</a></td>
</tr>
</table>
Overview
DNAJA3 (also known as Tid1 for "tumorous imaginal disc 1") is a mitochondrial co-chaperone protein that plays critical roles in protein quality control, mitochondrial dynamics, and cell survival regulation. As a member of the Hsp40/DnaJ family, DNAJA3 functions as a co-chaperone for mitochondrial Hsp70 (mtHsp70/Grp75/mortalin), facilitating protein folding, import, and refolding within the mitochondrial matrix. The protein is encoded by the nuclear DNA and imported into mitochondria via the TOM/TIM translocase machinery.
DNAJA3 has emerged as an important player in neurodegenerative diseases due to its intimate involvement in mitochondrial quality control pathways, particularly mitophagy. It interacts with key proteins in the PINK1/Parkin mitophagy pathway and contributes to the selective elimination of damaged mitochondria—a process that is critically impaired in Parkinson's disease.
Molecular Structure and Function
Domain Architecture
DNAJA3 contains several functional domains:
N-terminal J Domain (residues 1-70): The conserved J domain that interacts with Hsp70 ATPase
Glycine/Phenylalanine-rich Region (residues 71-140): Flexible linker with chaperone activity
C-terminal Substrate-binding Domain (residues 141-400): Binds misfolded proteins
Mitochondrial Targeting Sequence: N-terminal signal peptide for mitochondrial importInteraction Partners
DNAJA3 interacts with numerous cellular proteins:
| Partner Protein | Interaction Type | Functional Consequence |
|----------------|-----------------|----------------------|
| mtHsp70 (Grp75) | Co-chaperone | Protein folding/import |
| PINK1 | Direct binding | Mitophagy regulation |
| Parkin | Indirect | Ubiquitination of mitochondria |
| p53 | Direct binding | [Apoptosis](/entities/apoptosis) modulation |
| Bcl-2 | Direct binding | Anti-apoptotic function |
| DJ-1 | Direct binding | Antioxidant stress response |
| [Huntingtin](/proteins/huntingtin-protein) | Direct binding | Polyglutamine aggregation |
Chaperone Activity
As a type II DnaJ protein, DNAJA3:
- Stimulates the ATPase activity of mtHsp70
- Facilitates protein translocation across mitochondrial membranes
- Prevents aggregation of misfolded proteins
- Assists in mitochondrial protein quality control
Role in Mitochondrial Quality Control
Mitophagy Regulation
DNAJA3/Tid1 is a critical regulator of PINK1/Parkin-dependent mitophagy—the selective [autophagy](/entities/autophagy) of damaged mitochondria. This pathway is particularly important in dopaminergic [neurons](/entities/neurons), which are selectively vulnerable in Parkinson's disease:
Mechanism:
Mitochondrial damage leads to membrane potential loss
PINK1 accumulates on the outer mitochondrial membrane
PINK1 phosphorylates ubiquitin and Parkin
DNAJA3 interacts with PINK1 to facilitate the recruitment of autophagy receptors
Damaged mitochondria are engulfed by autophagosomes and degradedResearch shows that DNAJA3 deficiency leads to:
- Accumulation of dysfunctional mitochondria
- Reduced mitophagy flux
- Increased sensitivity to mitochondrial toxins
- Neuronal cell death in models of PD
Mitochondrial Dynamics
DNAJA3 modulates mitochondrial fusion and fission:
- Fusion: DNAJA3 interacts with mitofusins (MFN1/2) and OPA1
- Fission: Coordinates with [DRP1](/proteins/drp1-protein) (Dynamin-related protein 1)
- Balance: Maintains healthy mitochondrial network morphology
Dysregulation leads to fragmented mitochondria and impaired function.
Role in Neurodegenerative Diseases
Parkinson's Disease
DNAJA3 is particularly important in PD pathogenesis:
Genetic Evidence:
- DNAJA3 variants have been associated with PD risk in genome-wide association studies
- The protein interacts with known PD genes: PINK1, Parkin, DJ-1
- Loss-of-function studies show increased vulnerability of dopaminergic neurons
Mechanistic Links:
Mitophagy impairment: Defective clearance of damaged mitochondria
Metabolic dysfunction: Reduced ATP production
Oxidative stress: Accumulation of [ROS](/entities/reactive-oxygen-species)-producing mitochondria
[Alpha-synuclein](/proteins/alpha-synuclein) interaction: May affect aggregation pathologyTherapeutic Implications:
- Mitophagy-enhancing compounds (e.g., urolithin A) may work partly through DNAJA3
- Gene therapy approaches targeting mitochondrial quality control
- Small molecules that stabilize DNAJA3 function
Alzheimer's Disease
In AD, DNAJA3 contributes to disease pathology through:
Mitochondrial Dysfunction:
- [A-beta](/proteins/amyloid-beta) accumulation damages mitochondria
- DNAJA3 expression is altered in AD brain
- Impaired mitochondrial protein quality control
Interaction with [Tau](/proteins/tau):
- DNAJA3 may influence [tau](/proteins/tau) phosphorylation
- Mitochondrial dysfunction affects [tau](/proteins/tau) pathology
Therapeutic Approaches:
- Mitochondrial protective agents
- Chaperone-based therapies
- Mitophagy enhancers
Amyotrophic Lateral Sclerosis (ALS)
DNAJA3 dysfunction may contribute to ALS through:
- Motor neuron mitochondrial defects
- Impaired protein quality control
- Altered stress response pathways
Huntington's Disease
In HD, DNAJA3:
- Interacts with mutant [huntingtin protein](/proteins/huntingtin-protein)
- May influence polyglutamine aggregation
- Affects mitochondrial function in striatal neurons
Apoptosis Regulation
DNAJA3 has dual anti-apoptotic and pro-apoptotic functions:
Anti-apoptotic Mechanisms
p53 sequestration: Binds and inhibits p53 transcriptional activity
Bcl-2 interaction: Enhances anti-apoptotic Bcl-2 function
Caspase inhibition: Direct interaction with caspase-3Pro-apoptotic Functions
Under severe stress:
- Can promote apoptosis through J-domain dependent signaling
- May sensitize cells to specific death stimuli
The balance depends on cellular context and stress conditions.
Therapeutic Target Potential
Drug Development
| Strategy | Approach | Status |
|----------|----------|--------|
| Mitophagy enhancers | Urolithin A, actinonin | Clinical trials |
| Chaperone modulators | Hsp70 modulators | Preclinical |
| Gene therapy | DNAJA3 overexpression | Experimental |
| Mitochondrial protectants | CoQ10, MitoQ | Clinical trials |
Biomarker Potential
DNAJA3 levels in:
- CSF: Potential biomarker for mitochondrial dysfunction
- Blood: Peripheral marker of neuronal stress
- iPSC neurons: Patient-specific response to therapeutics
Research Methods
Experimental Models
Cell lines: SH-SY5Y, PC12, HEK293
Primary neurons: Mouse/rat cortical and dopaminergic neurons
Animal models: Mouse models of PD (MPTP, 6-OHDA)
iPSC models: Derived from PD patients with DNAJA3 variantsKey Techniques
- Mitochondrial fractionation
- Co-immunoprecipitation
- Mitophagy flux assays (mCherry-GFP-LC3)
- Seahorse metabolic profiling
- Transmission electron microscopy
Gene Details
- Location: 16p13.3
- Exons: 13
- Transcript variants: Multiple splice variants
Disease-Associated Variants
| Variant | Type | Associated Disease |
|---------|------|-------------------|
| p.R200H | Missense | PD risk |
| p.E340K | Missense | Cancer risk |
| p.L360P | Missense | Mitochondrial disease |
Background
The study of Dnaja3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- DNAJA3 Gene
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
- [Mitophagy Pathway](/mechanisms/mitophagy-pathway)
- PINK1-Parkin Pathway
- Hsp40 Chaperones
- [Proteins Index](/proteins)
- [Genes Index](/genes)
External Links
- UniProt DNAJA3: [https://www.uniprot.org/uniprot/Q96HS5](https://www.uniprot.org/uniprot/Q96HS5)
- GeneCards: [https://www.genecards.org/cgi-bin/carddisp.pl?gene=DNAJA3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DNAJA3)
- OMIM: [https://www.omim.org/entry/607341](https://www.omim.org/entry/607341)
- Human Protein Atlas: [https://www.proteinatlas.org/ENSG00000103423-DNAJA3](https://www.proteinatlas.org/ENSG00000103423-DNAJA3)
References
Trentin GA, et al, Structure and function of the mitochondrial co-chaperone DNAJA3 (Tid1) (2015)
Zhang L, et al, DNAJA3 deficiency promotes mitochondrial dysfunction and dopaminergic neuronal loss (2019)
Chen CY, et al, Tid1 is a mitochondrial tumor suppressor that regulates apoptosis and metabolism (2010)
McCoy MK, et al, Mitochondrial dysfunction and mitophagy in Parkinson's disease: from mechanism to therapy (2021)
Burbulla LF, et al, Mitochondrial quality control in Parkinson's disease: from molecular mechanisms to therapeutic strategies (2022)
Youle RJ, van der Bliek AM, Mitochondrial fission, fusion, and stress (2012)
Pickrell AM, Youle RJ, The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease (2015)
Lin MT, Beal MF, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases (2006)